Lifeward (NASDAQ:LFWD) Upgraded to “Hold” at Zacks Research

Zacks Research upgraded shares of Lifeward (NASDAQ:LFWD) from a strong sell rating to a hold rating in a report published on Monday morning,Zacks.com reports.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a report on Friday, July 17th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $10.00.

Lifeward Price Performance

Shares of Lifeward stock opened at $6.99 on Monday. The stock has a market capitalization of $19.63 million, a price-to-earnings ratio of -0.36 and a beta of 0.37. The firm’s 50-day moving average price is $7.39 and its two-hundred day moving average price is $7.05. The company has a current ratio of 2.40, a quick ratio of 1.82 and a debt-to-equity ratio of 1.16. Lifeward has a 1-year low of $4.14 and a 1-year high of $10.56.

Lifeward (NASDAQ:LFWD) last posted its earnings results on Friday, May 15th. The company reported ($6.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.18) by ($5.52). The firm had revenue of $3.92 million during the quarter, compared to the consensus estimate of $5.78 million. Lifeward had a negative net margin of 123.66% and a negative return on equity of 243.14%. On average, equities analysts predict that Lifeward will post -4.27 earnings per share for the current fiscal year.

Institutional Trading of Lifeward

Several hedge funds have recently modified their holdings of LFWD. Citadel Advisors LLC increased its holdings in shares of Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares in the last quarter. Jane Street Group LLC boosted its position in Lifeward by 77.3% in the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after buying an additional 29,927 shares during the last quarter. Virtu Financial LLC boosted its position in Lifeward by 158.0% in the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after buying an additional 37,037 shares during the last quarter. Finally, HRT Financial LP increased its stake in shares of Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after buying an additional 29,423 shares during the period. 26.76% of the stock is owned by institutional investors.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.